Jones Trading stays Buy on Precision BioSciences Inc. (DTIL) following Ph1/2 trial design announcement
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 11/4/2026
- Wall Street rallies after Democrats win Congress; data center stocks slide
- What the Democratic sweep in the midterms means for markets
- SpaceX, Tesla slide as election risks mount, Morgan Stanley turns bullish
- CVS Health plans to split into two public companies by 2028
- AI sector outlook darkens as Democrat wins threaten $900B capex cycle
| (NASDAQ: DTIL) | Delayed: 7.48 +0.51 (7.32%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $6.97 | 52 Week High | $ | |||
| Open | $7.21 | 52 Week Low | $ | |||
| Day High | $7.55 | P/E | N/A | |||
| Day Low | $7.14 | EPS | $ | |||
| Volume | 91,024 | |||||
